Diabetes drug Ozempic Shortage in UK: Touted as weight-loss drug
- What role do Macrophages play in Tumor Immunotherapy?
- Menstrual Cycle May Affect Insulin Sensitivity
- Infection with Monkeypox Virus Induces Natural Immunity to Prevent Re-Infection
- Painkillers and Contraceptives: Risky Combination for Women
- IAEA Shutdown Soon Due to Japan Nuclear Water and Australia Submarines?
- Baby Crying Elicits Oxytocin Release in Mothers
Diabetes drug Ozempic Shortage in UK: Touted as weight-loss drug
- Nearly 300 People Food Poisoning in Japanese 130-Year Restaurant
- FDA’s First Potential TIL Therapy Review Delayed: How to Understand FDA’s “Resource Constraints”?
- A Chinese Doctor Accused of Accepting Bribes Totaling US$166 Million
- Nuclear contaminated water: Japanese government paid bribes and corrected the IAEA report
- Top 20 Companies of Instruments and Medical Equipment In The World
- The first DMD gene therapy SRP-9001 may cost 4 million US dollars
- How long can the patient live after heart stent surgery?
Diabetes drug Ozempic Shortage in UK: Touted as weight-loss drug
Pharmacies in UK are facing a “severe shortage” of type 2 diabetes drug Ozempic (Semaglutide) as it is increasingly promoted as a weight-loss wonder drug by celebrities including the Kardashians and Elon Musk, putting at risk diabetics who really need it to save their lives.
The UK Department of Health and Social Care has confirmed that the country is experiencing a shortage of Ozempic that will not be resolved “until at least mid-2024”.
A pharmacist named Ali Abass expressed his concerns, saying: “Most patients have no other options. A lot of people won’t use anything else.”
Some people with diabetes said they were “very concerned” because Ozempic was the only drug that worked for them. One patient, Marie Indge, said she only had about two months of medication left and was concerned about finding an alternative to manage her condition.
The UK’s medicines watchdog urged diabetics to “must preserve existing stocks”.
Information about Ozempic:
Ozempic, whose generic name is semaglutide, is a prescription medication used to treat type 2 diabetes mellitus.
It belongs to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists).
GLP-1 receptor agonists work by mimicking the action of the GLP-1 hormone, which helps regulate blood sugar levels in the body.
Semaglutide helps lower blood sugar levels by increasing insulin production and reducing the release of glucose from the liver.
It also slows down the emptying of the stomach, which can help with appetite control and weight management in some individuals.
Ozempic is typically administered as a once-weekly injection using a pre-filled pen.
The dosage may vary based on individual needs, and it is important to follow the prescribed dose and administration instructions provided by a healthcare professional.
It is worth noting that Ozempic is not recommended for the treatment of type 1 diabetes or diabetic ketoacidosis (a serious complication of diabetes).
It is essential to inform your doctor about any other medications you are taking and any medical conditions you have before starting Ozempic, as it may interact with certain drugs or be contraindicated in specific situations.
As with any medication, Ozempic may have side effects, and it is crucial to discuss potential risks and benefits with your doctor to determine if it is a suitable option for your diabetes management.
Always follow your healthcare provider’s recommendations and monitor your blood sugar levels regularly while taking Ozempic.
(source:internet, reference only)
Disclaimer of medicaltrend.org
